ArticleResearch square2023

The Safety and Efficacy of Systemic Delivery of a New Liver-de-targeted TGFβ Signaling Inhibiting Adenovirus in an Immunocompetent Triple Negative Mouse Mammary Tumor Model.

Weidong Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.